Rituximab reduced proteinuria among patients with Type I MPGN. This trial suggests that B cells may play a role in this disease and that additional study of B-cell suppression is warranted.
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA. dillon.john [at] mayo.edu
Clin Nephrol. 2012 Apr;77(4):290-5
© Galenicom 1999-2013